Close Menu

The Scan

A blogger's take on British Telecom's thought for the future of biopharma.

Back for More

Craig Venter returns to the Colbert Report.

Advice to science grad students: it's hard work.

Theoretical chemist Leslie Orgel dies from pancreatic cancer.

Francis S. Collins is awarded the Presidential Medal of Freedom.

A blogger explains peer review to the industry crowd.

A new book explores evil genes.

Steven Salzberg wonders if "conservative" means "anti-knowledge."

PLoS Computational Biology launches a new series of articles.

Jonathan Eisen lists what he likes about Cold Spring Harbor.

VC biotech funding is decreasing.

"Watson's Folly" is a warning, says Seven Stones blogger.

Nobel laureate Arthur Kornberg dies at 89.

The New York Times points out other Nobel laureates who went off the deep end.

The Economist offers an article on systems biology.

Keith Robison blogs about the second GPCR to be successfully crystallized and have its structure published.

Science reports on decision making, Neandertal's hair and skin, and programmed cell death.

VentureBeat reports on diagnostic firm XDx, which just filed for an IPO.

NAR has a good backgrounder on DNA sequencing from Clyde Hutchison.

Motley Fool has a quick earnings analysis of Illumina.

Nature has American funding problems, Italian bioethics, epigenetic silencing of Ras, and more.

Derek Lowe blogs about pharma layoffs.

James Watson retires from Cold Spring Harbor.

Craig Venter's book is panned by the Washington Post.

Too Close to Home

An Invitrogen employee is at the center of an article about a family's escape from the California wildfires.


A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.

A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.

A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.

At the Guardian, the University of Edinburgh's Nikolay Ogryzko argues that universities need to better invest in postdocs' careers.